Showing posts with label Endometrial cancer;endometrial thickness;transvaginal ultrasound. Show all posts
Showing posts with label Endometrial cancer;endometrial thickness;transvaginal ultrasound. Show all posts

Tuesday, January 24, 2017

SMFM recommendations for routine cervical length screening for preventing Preterm Births.


Courtesy: Pixabay 

A summary of Society for Maternal-Fetal Medicine  recommendation for Cervical Length ( CL) screening to prevent Preterm births. 

Preterm birth (PTB) remains a major cause of neonatal death and short and long term disability across the globe. The current global preterm birth rate is 5% to 18% and statistic shows a steady increase recently. CDC data quotes that in the year 2014, every 1 in 10 infants was born preterm in US. 

 Nearly 2/3 of 15 million preterm births are spontaneous with a very high recurrence. A history of previous PTB is the strongest risk factor for preterm delivery in the current pregnancy. Among various other contributing factors prior uterine surgery, especially those performed on cervix (induced termination of pregnancy (I-TOP) or spontaneous abortion (SAB)) has been implicated in its causation.

There are few laboratory tests to predict preterm birth in a pregnancy.

Transvaginal Cervical Length measurement helps in predicting the risk of preterm birth so the obstetrician and his team gets time to intervene, delay or transfer the patient to high risk units.
At present, a single mid-trimester transvaginal CL measurement is the best clinical predictor of a preterm birth. Those with the shortest cervix has the highest risk of prematurity.

The Society for Maternal-Fetal Medicine issued recommendation about the role of routine cervical length screening in selected high-and low-risk women for preterm birth prevention.

  • SMFM recommends “routine transvaginal cervical length screening for women with singleton pregnancy and history of prior spontaneous preterm birth (GRADE 1A).”


Transvaginal assessment at 16 and 24 weeks’ gestation by a trained sonologist or obstetrician should be performed. Routine CL screening is not advisable before 16 weeks and after 24 weeks in asymptomatic women.  

In women with prior history of preterm births serial CL measurements are performed every week beginning at 16 weeks to 24 weeks.

  • SMFM recommends “Practitioners who decide to implement universal CL screening should follow strict guidelines (GRADE 2B).”
  • SMFM recommends “Routine transvaginal CL screening not be performed for women with cervical cerclage, multiple gestation, PPROM, or placenta previa (GRADE 2B).”

Evidence does not support additional screening for women who have undergone cervical conning or LEEP beyond the standard recommendations.

No additional clinical benefit is derived for repeated CL screening in women who have undergone cerclage operation. Although research demonstrates that progressive CL shortening after the stitch increases the risk for PTB, but no options exist to reinforce the short cervix after cerclage.

Routine cervical screening is not recommended by SMFM in multiple gestation as no additional clinical benefit is derived from it.

Transvaginal CL measurement serves as an adjunct to fetal fibronectin (FFN) in predicting PTB in women with CL of 20-29 mm (the grey zone). Cervical length more than 30 mm and less than 20 mm is independently a strong predictor of minimum chances for PTB or high risk for  PTB respectively. 

Not much clinical benefit is derived from cervical length estimate in Preterm premature rupture of membranes (PPROM). Few observational studies have shown that with a transvaginal CL <2 cm, the positive predictive value of delivery within 7 days was 62%.

Routine transvaginal CL measurement is not performed in case of placenta previa as studies do not show any additional benefit is derived for management.
  • SMFM recommends “sonographers and/or practitioners receive specific training in the acquisition and interpretation of cervical imaging during pregnancy”.

Steps for proper cervical length measurement as recommended by SMFM.[1]

(1) Ensure patient has emptied her bladder.
(2) Prepare the cleaned probe using a probe cover.
 (3) Gently insert the probe into the patient’s vagina.
 (4) Guide the probe into the anterior fornix.
 (5) Obtain a sagittal, long-axis image of the entire cervix.
(6) Remove the probe until the image blurs and then reinsert gently until the image clears (this ensures you are not using excessive pressure).
(7) Enlarge the image so that the cervix occupies two thirds of the screen.
 (8) Ensure both the internal and external os are seen clearly.
 (9) Measure the cervical length along the endocervical canal between the internal and external os.
(10) Repeat this process twice to obtain 3 sets of images/ measurements.
(11) Use the shortest best measurement.




[1] SMFM. Role of routine cervical length screening for preterm birth prevention. Am J Obstet Gynecol 2016.

Monday, February 8, 2016

Reassessment of endometrial thickness for detecting endometrial cancer in post menopausal bleeding: a retrospective cohort study.




Postmenopausal bleeding (PMB) accounts for 5% of all gynecological consultations out of whom nearly 10% will be diagnosed with endometrial cancer as the cause of bleeding making it to be the most common malignancy of female genital tract.

Endometrial cancer is the fourth most common cancer in females in the UK (2012), accounting for 5% of all new cases of cancer in females.

The liberal use of Transvaginal Ultrasound (TVS) as the first line of investigation in patients with PMB has decreased the use of more invasive procedures like endometrial sampling and hysteroscopy.

Based on the very high negative predictive value of TVS, ACOG recommended a cutoff of 4 mm for endometrial thickness: That is, endometrial stripes 4 mm or thinner require no endometrial sampling; only those thicker than 4 mm require a biopsy.

RCOG guidelines for investigation of PMB have also set the arbitrary cutoff at 4-5 mm by TVS at which the women can be reassured.

However, the endometrial thickness cutoff and the need for further investigation are being debated since very long.

A literature review showed that 4 different meta-analysis have been published on this subject showing varying conclusions. All 4 Meta analyses suffered from various biases like verification bias because the endometrial biopsy was conditioned upon the endometrial thickness by TVS.

A recent study by Wong et al published in the February issue of BJOG:An International Journal of Obstetrics & Gynaecology and the Mini Commentary is unique because it constituted the largest cohort of women (4383 women) with PMB, in whom endometrial biopsy was performed independent of the endometrial thickness by TVS. Endometrial histology results were used as the reference standard to calculate accuracy estimates.

Endometrial cancer was diagnosed in 3.8% of all the women, with a median endometrial thickness of 15.7 mm which was much higher than that found in benign conditions (3.2mm).

The sensitivity for the diagnosis of endometrial cancer at 3, 4 and 5mm cutoff were 97%, 94.1% and 93.5% respectively with corresponding estimates for specificity 45.3% ,66.8% and 74.0% respectively.

According to this study the optimal threshold that combines the perfect sensitivity with an acceptable specificity appears to be 3 mm.

At this cut-off point, positive and negative predictive values were 6.5 and 0.26%.

Although the strategies to diagnose endometrial cancer by TVS are well documented, further improvement can be achieved by adding patient’s characteristics and individual risk factors to decide the need and type of testing required.

This study and the resulting data can further validate and add to the existing prediction models to maximize the probabilities of pre and post test diagnosis of endometrial cancer!

This will in turn be able to pinpoint women who are least likely to have endometrial cancer based on TVS screening, avoiding unnecessary invasive surgeries.


References:

Wong AS-W, Lao TT-H, Cheung CW, Yeung SW, Fan HL, Ng PS, Yuen PM, Sahota DS. Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study. BJOG 2016;123:439446.

Breijer, M. and Mol, B. (2016), Transvaginal ultrasound measurement of the endometrium remains the first line test for investigating postmenopausal bleeding but integration of patient characteristics into testing may further improve diagnostic algorithms. BJOG: An International Journal of Obstetrics & Gynaecology, 123: 447. doi: 10.1111/1471-0528.13438